UTSA and GenCure enter into agreement for cell therapy collaboration

The University of Texas at San Antonio (UTSA) and GenCure, a subsidiary of the San Antonio nonprofit BioBridge Global, have entered into an agreement to collaborate on the development of cellular therapy products, services, and testing.

The agreement covers two major areas whereby UTSA receives research starting materials and GenCure gets capability development and testing services.